Water- and Salt-homeostasis in Healthy Humans, and in Patients With Heart- or Lung Disease
NCT ID: NCT00830726
Last Updated: 2011-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2009-02-28
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Urinary Aquaporin 2 and Expression of the NPHS2 Gene in Adults Suffering From Nephrotic Syndrome
NCT00286910
The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT04363554
Relationship of Brain Natriuretic Peptide (BNP) Levels to Cardiac Diagnosis, Operation Performed, Post-operative Course and Outcome
NCT00238810
Fluid Balance During Closure of Atrial Septal Defect
NCT01757743
Subclassification of the Syndrome of Inappropriate ADH Secretion
NCT01341665
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Healthy volunteers
No interventions assigned to this group
2
Patients with symptomatic heart failure and EF \< 40%
Pharmacologic and mechanical heart failure treatment
Optimised, standard, evidence based heart failure therapy including the use of biventricular pacing.
3
Patients with symptomatic aortic valve stenosis
Aortic valve replacement
Standard aortic valve replacement as per standard criteria in the department of thoracic surgery.
4
Patients with Acute Coronary syndromes prior to surgical intervention
Revascularisation in Acute Coronary Syndrome
Standard percutaneous or surgical revascularisation in ACS.
5
Patients with refractory stable angina requiring surgical intervention.
Revascularisation in chronic stable angina pectoris
Standard percutaneous or surgical revascularisation
6
Patients with pulmonary hypertension and preserved systolic left ventricular function.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pharmacologic and mechanical heart failure treatment
Optimised, standard, evidence based heart failure therapy including the use of biventricular pacing.
Aortic valve replacement
Standard aortic valve replacement as per standard criteria in the department of thoracic surgery.
Revascularisation in Acute Coronary Syndrome
Standard percutaneous or surgical revascularisation in ACS.
Revascularisation in chronic stable angina pectoris
Standard percutaneous or surgical revascularisation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Severe valvular aortic stenosis
* Acute Coronary Syndrome
* Medically refractory chronic angina pectoris or pulmonary hypertension with preserved left ventricular function
Exclusion Criteria
* Drug abuse
* Malignant disease
* Significant disease of other organs including endocrine diseases
30 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Regionshospitalet Holstebro, Holstebro, Denmark
UNKNOWN
Odense University Hospital
OTHER
Kolding Sygehus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kolding Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ole Nyvad, M.D.
Role: PRINCIPAL_INVESTIGATOR
Kolding Hospital, Kolding, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kolding Hospital
Kolding, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-20080141
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.